AU2002223275A1 - A method of expression and agents identified thereby - Google Patents

A method of expression and agents identified thereby

Info

Publication number
AU2002223275A1
AU2002223275A1 AU2002223275A AU2327502A AU2002223275A1 AU 2002223275 A1 AU2002223275 A1 AU 2002223275A1 AU 2002223275 A AU2002223275 A AU 2002223275A AU 2327502 A AU2327502 A AU 2327502A AU 2002223275 A1 AU2002223275 A1 AU 2002223275A1
Authority
AU
Australia
Prior art keywords
expression
agents identified
agents
identified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002223275A
Other languages
English (en)
Inventor
Anthony John Mason
Simon Peter Tucker
Paul R. Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Publication of AU2002223275A1 publication Critical patent/AU2002223275A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2002223275A 2000-11-22 2001-11-22 A method of expression and agents identified thereby Abandoned AU2002223275A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25276700P 2000-11-22 2000-11-22
US60/252,767 2000-11-22
PCT/AU2001/001517 WO2002042326A1 (fr) 2000-11-22 2001-11-22 Procede d'expression et agents identifies a l'aide de ce dernier

Publications (1)

Publication Number Publication Date
AU2002223275A1 true AU2002223275A1 (en) 2002-06-03

Family

ID=22957457

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002223275A Abandoned AU2002223275A1 (en) 2000-11-22 2001-11-22 A method of expression and agents identified thereby

Country Status (3)

Country Link
US (1) US20040161846A1 (fr)
AU (1) AU2002223275A1 (fr)
WO (1) WO2002042326A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100481879B1 (ko) * 2001-02-08 2005-04-11 크레아젠 주식회사 (+)-단일쇄 ｒｎａ 재조합 벡터내 삽입 서열의 유전적 안정성을 증가시키는 방법
EP2319318A3 (fr) 2003-03-27 2011-08-17 PTC Therapeutics, Inc. METHODES D'IDENTIFICATION DE COMPOSES QUI CIBLENT L'ENDONUCLEASE POUR L'EPISSAGE DE L'ARNt ET UTILISATIONS DE CES COMPOSES COMME AGENTS D'ANTI-PROLIFERATION
WO2004087070A2 (fr) 2003-03-27 2004-10-14 Ptc Therapeutics, Inc. Procedes d'identification de composes ciblant l'endonuclease d'epissage d'arnt et utilisations desdits composes comme agents antifongiques
EP1649002A4 (fr) 2003-07-02 2009-06-03 Ptc Therapeutics Inc Complexes proteiniques de traitement de l'arn et utilisations associees
CN101723949B (zh) 2003-12-24 2013-10-23 生物区科学管理控股有限公司 用于治疗呼吸道合胞体病毒感染的多环试剂
TWI423972B (zh) 2006-09-28 2014-01-21 Biota Scient Management 治療呼吸系融合細胞病毒感染之多環劑
EP2074232A4 (fr) * 2006-10-09 2010-01-20 Siemens Healthcare Diagnostics Procedes de criblage d'un virus respiratoire syncytial et d'un metapneumovirus humain
US8772256B2 (en) * 2006-11-30 2014-07-08 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Codon modified immunogenic compositions and methods of use
JP2010534057A (ja) 2007-03-06 2010-11-04 シムフォゲン・アクティーゼルスカブ 呼吸器合胞体ウイルス感染症を治療するための組換え抗体
WO2008154456A2 (fr) * 2007-06-06 2008-12-18 Nationwide Children's Hospital, Inc. Procédés et compositions liés à des protéines de fusion virales
DK2222710T3 (en) 2007-12-24 2016-10-03 Id Biomedical Corp Quebec Recombinant RSV antigens.
WO2009128949A2 (fr) * 2008-04-18 2009-10-22 Vaxinnate Corporation Compositions de proteines du virus de la dengue et methodes d’utilisation associees
EA201170217A1 (ru) * 2008-07-18 2011-08-30 АйДи БАЙОМЕДИКАЛ КОРПОРЕЙШН ОФ КВЕБЕК Гибридные полипептидные антигены респираторно-синцитиального вируса
WO2010039224A2 (fr) * 2008-09-30 2010-04-08 University Of Massachusetts Medical School Séquences du virus syncytial respiratoire (rsv) destinées à l'expression de protéines et aux vaccins
WO2010149743A2 (fr) 2009-06-24 2010-12-29 Id Biomedical Corporation Of Quebec Vaccin
PE20121541A1 (es) * 2009-06-24 2012-12-21 Glaxosmithkline Biolog Sa Antigenos de virus de sincicio respiratorio recombinantes
EP4218799A1 (fr) 2009-07-15 2023-08-02 GlaxoSmithKline Biologicals S.A. Compositions de protéine f rsv et leurs procédés de fabrication
US20110097358A1 (en) * 2009-10-12 2011-04-28 Techno Vax, Inc. RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs)
TWI508968B (zh) 2010-02-08 2015-11-21 Biota Scient Management 用於治療呼吸道融合性病毒感染的化合物
US8796303B2 (en) 2010-11-26 2014-08-05 Biota Scientific Management Pty Ltd. Imidazo[2,1-G][1,7]naphthyridines for treating respiratory syncytial virus infections
BR112013018845A2 (pt) * 2011-01-28 2016-07-19 Medimmune Llc expressão de glicoproteínas de fusão viral solúveis em células de mamífero
JP5890522B2 (ja) 2011-08-05 2016-03-22 ビオタ サイエンティフィック マネージメント ピーティーワイ リミテッド 呼吸器合胞体ウイルス感染症処置用化合物
PL2954049T3 (pl) 2013-02-08 2023-10-16 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Atenuacja ludzkiego syncytialnego wirusa oddechowego przez deoptymalizację par kodonów w skali genomu
US20160228536A1 (en) * 2013-09-18 2016-08-11 Medimmune, Llc Recombinant respiratory syncytial virus (rsv) and vaccines
JP7198759B2 (ja) 2016-09-23 2023-01-04 ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンテッド・バイ・ザ・セクレタリー・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシーズ 弱毒化表現型を有するヒト呼吸器多核体ウイルス（ｒｓｖ）のためのワクチン候補

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619942A (en) * 1982-04-08 1986-10-28 University Of North Carolina Inhibition of Respiratory Syncytial virus-induced cell fusion by amidino compounds
US5786464C1 (en) * 1994-09-19 2012-04-24 Gen Hospital Corp Overexpression of mammalian and viral proteins
DK0780475T4 (da) * 1995-08-09 2006-10-23 Schweiz Serum & Impfinst Fremgangsmåde til fremstilling af infektiöse negativ-streng RNA-virus
JP4434479B2 (ja) * 1997-07-09 2010-03-17 ザ・ユニバーシティ・オブ・クイーンズランド 標的の細胞および組織においてタンパク質を選択的に発現するための核酸配列および方法
US6814968B1 (en) * 1998-06-04 2004-11-09 Vanderbilt University Inhibition of viral infection and spread with viral and RhoA-derived peptides
US6924365B1 (en) * 1998-09-29 2005-08-02 Transkaryotic Therapies, Inc. Optimized messenger RNA
EP1141313A2 (fr) * 1998-12-31 2001-10-10 Chiron Corporation Expression amelioree de polypeptides hiv et production de particules de type viral

Also Published As

Publication number Publication date
WO2002042326A1 (fr) 2002-05-30
US20040161846A1 (en) 2004-08-19
WO2002042326A8 (fr) 2002-09-06

Similar Documents

Publication Publication Date Title
AU2002223275A1 (en) A method of expression and agents identified thereby
AU2001269511A1 (en) Resilient Bush and Method of Pressure-Insertion of a Resilient Bush
EP1306573A4 (fr) Douille elastique et procede pour adapter par pression une douille elastique
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU4500901A (en) A method of performing a transaction
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2001265052A1 (en) Package kit and method
AU2001281078A1 (en) A mem gyroscope and a method of making same
AU2000278326A1 (en) Interactive and animated mini-theater and method of use
AU2000256360A1 (en) Method of providing a fire barrier and article therefor
EP1170035A3 (fr) Procédé et dispositif d'optimisation de l'utilisation d'un dispositif de bronzage
AU2001279850A1 (en) Method and arrangement for studsystem
AUPQ582400A0 (en) A method of treatment and agents for use therein
AU2002215876A1 (en) Structural member and a method of manufacturing said member
AUPQ614700A0 (en) A method and agents useful for same
AUPQ592100A0 (en) A method of treatment and prophylaxis
AU2002256556A1 (en) Sea-trosy and related methods
AUPQ639300A0 (en) Method of enhancing or maintaining a relationship
HUP0105421A2 (en) Shaped part and a method of forming same
AUPQ199999A0 (en) A method of treatment and agents useful for same
AUPQ656500A0 (en) A method of treatment and agents for same
AUPR666501A0 (en) A method for selection and agents useful for same
AUPQ800300A0 (en) A method of treatment and agents useful for same
AUPQ645500A0 (en) A method of treatment and agents useful for same
AUPQ762100A0 (en) A method of prophylaxis and treatment - III